Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas

Yumi Takiyama1, Naoyuki Miyokawa, Akira Sugawara

  • 1The Second Department of Internal Medicine, School of Medicine, Asahikawa Medical College, Midorigaoka higashi 2-1-1-1, Asahikawa 078-8510, Japan. taka0716@asahikawa-med.ac.jp.

Insights

Retinoid X receptors (RXRs) are crucial for thyroid cell function. This study found reduced nuclear RXR expression in thyroid carcinomas, suggesting their involvement in cancer development.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Retinoid X receptors (RXRs) are nuclear hormone receptors that form heterodimers with other receptors.
  • RXRs regulate critical signaling pathways involved in cellular processes.

Purpose of the Study:

  • To investigate the expression and localization of RXR isoforms in human thyroid carcinogenesis.
  • To determine the role of RXRs in the development of thyroid cancers.

Main Methods:

  • Immunohistochemical analysis of RXR expression in normal and neoplastic thyroid tissues.
  • Western blot analysis to confirm subcellular localization of RXR-alpha.

Main Results:

  • Nontumorous thyroid cells showed distinct nuclear RXR staining.
  • Thyroid carcinomas exhibited decreased nuclear expression of all three RXR isoforms (alpha, beta, gamma).
  • RXR-alpha displayed altered subcellular localization, with increased cytoplasmic and decreased nuclear presence in carcinomas.

Conclusions:

  • Reduced nuclear expression and altered localization of RXRs are observed in human thyroid carcinomas.
  • These differential expressions of RXRs may play a role in the pathogenesis of thyroid cancers.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...